Monotherapy with Lopinavir/Ritonavir as maintenance after HIV-1 viral suppression: results of a 96-week randomized, controlled, open-label, pilot trial (KalMo study).
作者:
主题词
成年人(Adult);抗逆转录病毒治疗, 高效(Antiretroviral Therapy, Highly Active);CD4淋巴细胞计数(CD4 Lymphocyte Count);复方合剂(Drug Combinations);抗药性, 病毒(Drug Resistance, Viral);女(雌)性(Female);HIV感染(HIV Infections);HIV蛋白酶抑制药(HIV Protease Inhibitors);HIV-1(HIV-1);人类(Humans);男(雄)性(Male);中年人(Middle Aged);试点项目(Pilot Projects);嘧啶酮类(Pyrimidinones);利托纳韦(Ritonavir);精液(Semen);时间因素(Time Factors);治疗结果(Treatment Outcome);病毒载量(Viral Load)
DOI
10.1310/hct1006-368
PMID
20133267
发布时间
2013-11-21
- 浏览10
HIV clinical trials
368-74页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文